Can the assessment of ABCB1 gene expression predict its function in vitro?
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 150, doi. 10.1111/ejh.12470
- By:
- Publication type:
- Article
Works matching IS 09024441 AND DT 2015 AND VI 95 AND IP 2
Results: 10
1
2
Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 160, doi. 10.1111/ejh.12474
- By:
- Publication type:
- Article
3
Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 168, doi. 10.1111/ejh.12477
- By:
- Publication type:
- Article
4
Acute myeloid leukemia in the pregnant patient.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 124, doi. 10.1111/ejh.12479
- By:
- Publication type:
- Article
5
Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 113, doi. 10.1111/ejh.12460
- By:
- Publication type:
- Article
6
Teasing Apart Pain in Sickle Cell Disease.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
7
Relationship of intratumoural protein expression patterns to age and Epstein- Barr virus status in classical Hodgkin lymphoma.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 137, doi. 10.1111/ejh.12463
- By:
- Publication type:
- Article
8
Paroxysmal nocturnal haemoglobinuria: to prednisone or not to prednisone? - a case report of a patient previously treated with steroids for 15 yrs and significant response on eculizumab.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 177, doi. 10.1111/ejh.12480
- By:
- Publication type:
- Article
9
Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3- and 6-month time points.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 2, p. 103, doi. 10.1111/ejh.12453
- By:
- Publication type:
- Article
10
Emerging role of CEBP-α mutations in acute myeloid leukemia.
- Published in:
- 2015
- By:
- Publication type:
- Editorial